While the results are promising in lab environments, DSIP is for research use only and not approved for human or animal use
Disclaimer: This product is intended for use by licensed healthcare professionals only
Suggested starting points to discuss with your clinician Deficiency without malabsorption: 1,0002,000 mcg oral cyanocobalamin daily until normalized, then weekly or monthly maintenance per labs (AAFP)
Applications include: Tendon repair biology Achilles tendon transection models, fibroblast outgrowth and migration, collagen synthesis, biomechanical load-to-failure restoration Ligament healing medial collateral and anterior cruciate ligament injury models, fibroblast recruitment, and collagen organisation Skeletal muscle repair muscle crush, transection, and degloving injury models, satellite cell activity, and functional research applications Bone healing fracture models, segmental bone defect, pseudoarthrosis research, and osteogenic effects Gastric mucosal biology cytoprotection, ulcer healing, gut permeability, ethanol and NSAID injury models Inflammatory bowel disease models colitis, short bowel syndrome, and intestinal anastomosis healing Liver and pancreas research hepatoprotection, acute hepatic injury, and pancreatic lesion models Angiogenesis research VEGFR2/Akt/eNOS pathway, vascular recruitment, and neovascularisation GHR/JAK2 pathway biology growth hormone receptor upregulation, collagen matrix synthesis, and IGF-1 axis sensitisation HO-1 antioxidant biology cytoprotection, oxidative stress modulation, and ischaemia-reperfusion protection FAK-paxillin cell motility research fibroblast migration, cell adhesion, and matrix remodelling Cardiovascular models fistula healing, endothelium protection, and cardiac arrhythmia models CNS and neuroprotection research serotonin syndrome models, dopaminergic modulation, neuroinflammation Corneal ulcer and wound healing ocular tissue repair and corneal neovascularisation models Anti-inflammatory research IL-6, TNF- modulation, and inflammatory cascade attenuation NSAID toxicity counteraction gut permeability protection and gastric mucosal rescue models Cancer cachexia models body weight restoration and IL-6/TNF- reduction in C26 adenocarcinoma mouse models Comparative growth factor pharmacology BPC-157 vs TGF-, EGF, VEGF, GDFs in tissue healing context What Do Studies Say About BPC-157
Proven results
This explains why BPC-157 for injury recovery is effective for athletes, surgery patients, and people with chronic injuries
